In the real world, treating relapsed/refractory large B-cell lymphoma with epcoritamab and glofitamab leads to poorer ...

However, finding a stable, active CD20 protein for antibody drug development and CD20 CAR expression is challenging due to issues with low expression levels and unstable bioactivity. To address ...

CD20 is crucial for the treatment of leukemia, lymphoma and certain autoimmune diseases. But as a result of the low expression titer and the unstable bioactivity, it is so hard to determine an ...

The non-cryopreserved CD19- and CD20-directed CAR T-cell therapy zamto-cel is manufactured in a closed-system device that ...

Rituximab is an anti-CD20 monoclonal antibody that suppresses inflammation effectively in autoimmune diseases. It was initially approved by the FDA for the treatment of B-cell lymphomas and later ...